Phase III Study in Refractory Behcet's Disease
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Phase III Study in Refractory Behcet's Disease is a clinical trial[1].
Key Facts
- Phase III Study in Refractory Behcet's Disease is located in Hong Kong[2].
- Phase III Study in Refractory Behcet's Disease is in the country of Egypt[3].
- Phase III Study in Refractory Behcet's Disease is in the country of France[4].
- Phase III Study in Refractory Behcet's Disease is in the country of Germany[5].
- Phase III Study in Refractory Behcet's Disease is in the country of Greece[6].
- Phase III Study in Refractory Behcet's Disease is in the country of India[7].
- Phase III Study in Refractory Behcet's Disease is in the country of Israel[8].
- Phase III Study in Refractory Behcet's Disease's instance of is recorded as clinical trial[9].
- Phase III Study in Refractory Behcet's Disease's start time is recorded as +2009-10-31T00:00:00Z[10].
- Phase III Study in Refractory Behcet's Disease's end time is recorded as +2010-07-31T00:00:00Z[11].
- Phase III Study in Refractory Behcet's Disease's sponsor is recorded as Novartis[12].
- Phase III Study in Refractory Behcet's Disease's main subject is recorded as intermediate uveitis[13].
- Phase III Study in Refractory Behcet's Disease's main subject is recorded as posterior uveitis[14].
- Phase III Study in Refractory Behcet's Disease's number of participants is recorded as {'unit': '1', 'amount': '+118'}[15].
- Phase III Study in Refractory Behcet's Disease's title is recorded as A 24 Week Multicenter, Randomized, Double-masked, Placebo Controlled Study to Assess the Difference in the Rate of Recurrent Exacerbations in Behçet¿s Patients With Posterior or Panuveitis Treated With AIN457 vs Placebo Adjunctive to Standard-of-care Immunosuppressive Therapy[16].
- Phase III Study in Refractory Behcet's Disease's short name is recorded as SHIELD[17].
- Phase III Study in Refractory Behcet's Disease's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[18].
- Phase III Study in Refractory Behcet's Disease's ClinicalTrials.gov ID is recorded as NCT00995709[19].
- Phase III Study in Refractory Behcet's Disease's clinical trial phase is recorded as phase III clinical trial[20].
- Phase III Study in Refractory Behcet's Disease's research site is recorded as Novartis[21].
- Phase III Study in Refractory Behcet's Disease's study type is recorded as interventional study[22].